fbpx

Analys

PROLIGHT: PoC troponin testing ready for next step

Analys, Research

With proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers even in whole blood, Prolight...

Read More

GRANGEX: Starting to fuel up: GRANGEX set for busy agenda in 2024 

Analys, Research

With the SEK 74 m (estimated 61m net) proceeds from the rights issue, we now look forward to the updated feasibility study initiated in...

Read More

NANEXA: Focus on dual GLP-1 opportunities and the partner projects

Analys, Research

Apart from a write down of capitalized development related to the suspended projects NEX-18 and NEX-20, there was not much new in...

Read More

FREE2MOVE: Growth and improved focus on profitability catalysts for steep revaluation

Analys, Research

As expected, Free2Move reported solid growth in Q4, achieving a 59% growth rate for the full year. However, foreign exchange (FX)...

Read More

CRUNCHFISH: Clearing the books in preparation for breakthrough in 2024

Analys, Research

In line with the already communicated ambition to divest its Gesture Interaction business, Crunchfish decided to write down all GI-related...

Read More

AGTIRA: Solid ending to 2023 before scaleup in 2024

Analys, Research

After several commercial contracts signed in 2023, Agtira ended the year with a strong cash position and only a few passing weaknesses in...

Read More

AGTIRA: Video interview (SWE) with CEO Erik Jonuks about LIDL, the outlook and when AGTIRA will be profitable

Analys, Research

READ OUR MOST RECENT EQUITY RESEARCH REPORT  AGTIRA: Lidl deal solid stepping stone for Agtira towards FaaS-profitability With the fresh...

Read More

CRUNCHFISH: Video interview with CEO (SWE) + Streamlining for breakthrough in 2024

Analys, Research

Video interview (in Swedish) with CRUNCHFISH CEO Joachim Samuelsson about the planned divestiture of Gesture Interaction and the...

Read More

PROLIGHT: Single molecule biomarker POC test upcoming

Analys, Research

Having already achieved proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers in low...

Read More

AGTIRA: Lidl deal solid stepping stone for Agtira towards FaaS-profitability

Analys, Research

With the fresh 10-year deal to supply Lidl from a new 10,000 sqm production facility in a FaaS-setup, Agtira is now about to get all the...

Read More

For new research on growth stocks, sign up to our newsletter